We have participated in a conference on “Medicine of the Future” at the Roche Institute.

We present the NANO4Glio project in Madeira.

  Through it, a new therapeutic approach for glioblastoma is developed based on using RNAi technology (more specifically siRNA) to reduce the cellular levels of proteins involved in the survival and proliferation of tumor cells.

+ info